🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Apogee Therapeutics, Inc.

APGE Healthcare
$134.55 +$0.1 (0.07%)
Market Cap: $10.15 B
Gurus Holding
8
Popularity Rank
#896
% of Shares Held
6.34%
Net Activity (Q2 2026)
+$46.78 M

Guru Ownership Trend

Guru Analysis for Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics, Inc. (APGE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $642.93 M.

Top institutional holders include George Soros and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $46.78 M net inflow during the quarter.

Recent activity highlights George Soros who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 73.9%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$103.06 M
Total Buy Value
New Buys 4
Additions 0
-$56.27 M
Total Sell Value
Reductions 4
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
4
Net Buyers
4

FAQs for Apogee Therapeutics, Inc. (APGE)

Major holders include George Soros ($74.93 M), Renaissance Technologies (RenTech) ($19.48 M), Jeremy Grantham ($18.24 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 4.78 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $46.78 M, with 4 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited APGE. The total reported sell value was $56.27 M.

Yes, 4 managers opened new positions in APGE, and 0 increased their existing holdings. The total reported buy value was $103.06 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.92% New Buy 564,500 $74.93 M Q2 2026
0.03% Reduce -73.9% 146,800 $19.48 M Q2 2026
0.04% New Buy 137,395 $18.24 M Q2 2026
0.07% Reduce -1.0% 3,657,548 $10.31 M Q2 2026
0.01% New Buy 54,559 $7.24 M Q2 2026
0.04% New Buy 20,000 $2.65 M Q2 2026
0.00% Reduce -0.9% 7,958 $1.06 M Q2 2026
0.00% Reduce -66.3% 189,628 $534,751 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form